Current position:Home >Product >
Sorafenib impurity 24/N-Methyl-4-[4-[[2-[(methylamino)carbonyl]-4-pyridinyl]amino]phenoxy]-2-pyridinecarboxamide
Sorafenib impurity 24/N-Methyl-4-[4-[[2-[(methylamino)carbonyl]-4-pyridinyl]amino]phenoxy]-2-pyridinecarboxamide(2004659-83-8)
- Name: Sorafenib impurity 24/N-Methyl-4-[4-[[2-[(methylamino)carbonyl]-4-pyridinyl]amino]phenoxy]-2-pyridinecarboxamide
- Synonyms:Sorafenib impurity 24/N-Methyl-4-[4-[[2-[(methylamino)carbonyl]-4-pyridinyl]amino]phenoxy]-2-pyridinecarboxamide;N-Methyl-4-[4-[[2-[(methylamino)carbonyl]-4-pyridinyl]amino]phenoxy]-2-pyridinecarboxamide;Sorafenib tosylate Impurity T;Sorafenib impurities164;Sorafenib impurities3;N-methyl-4-(4-((2-(methylcarbamoyl)pyridin-4-yl)amino)phenoxy)picolinamide? (Sorafenib Impurity）;2-Pyridinecarboxamide, N-methyl-4-[4-[[2-[(methylamino)carbonyl]-4-pyridinyl]amino]phenoxy]-;Sorafenib Impurity 08
- Molecular Formula:C20H19N5O3
- Molecular Weight:377.4
- CAS Registry Number:2004659-83-8
- EINECS:
- Melting Point:662.6±55.0 °C(Predicted)
- Water Solubility:
Other Product
- 2004208-50-6/4-(4,4-Difluoropiperidin-1-yl)-5-iodopyrimidine
- 200421-63-2/(3,4-dimethylphenyl)(2-nitrobenzylidene)amine
- 200423-07-0/4-Morpholineacetic acid, α-methyl-, methyl ester, (αS)-
- 200423-98-9/2'-O-Aminolinker-5-methyl U CEP
- 200425-72-5/(R)-4-methoxy-2,3-dihydro-1H-inden-1-ol
- 200425-74-7/(1R)-6-methoxy-2,3-dihydro-1H-inden-1-ol
- 200425-75-8/1H-Inden-1-ol, 2,3-dihydro-6-methoxy-, (1S)-
- 2004261-02-1/tert-butyl (5-methyl-3-nitro-1H-pyrazol-1-yl)acetate
- 2004295-23-0/Carbamic acid, N-[3-(aminocarbonyl)-3-thietanyl]-N-methyl-, 1,1-dimethylethyl ester
- 2004303-09-5/1-[Boc(methyl)amino]cyclopropanecarbonitrile
- 200431-50-1/3-(4-Pyridyl)-2H-benz(g)indazole
- 2004343-43-3/Ethanone, 1-[3-(1-methyl-1H-tetrazol-5-yl)phenyl]-
- 2004347-58-2/Benzenamine, 4-(3,3-difluoro-1-pyrrolidinyl)-3,5-difluoro-
- 20044-04-6/4-[[[1-Hydroxy-4-[(2-ethoxycarbonylphenyl)azo]-2-naphthalenyl]carbonyl]amino]isophthalic acid dioctyl ester
- 20044-78-4/1,2-Benzisothiazole,2,3-dihydro-2-(2-propyn-1-yl)-,1,1-dioxide
- 2004503-94-8/Butane, 1-bromo-3,3-difluoro-2,2-dimethyl-
- 2004510-50-1/1,1-Dimethylethyl 1-methyl-1H-pyrazole-3-acetate
- 2004594-41-4/Serine, N-[(1,1-dimethylethoxy)carbonyl]-2-methyl-O-phenyl-
- 2004650-47-7/Cyclopropanecarboxylic acid, 1-(1,1-difluoroethyl)-, ethyl ester
- 2004659-83-8/Sorafenib impurity 24/N-Methyl-4-[4-[[2-[(methylamino)carbonyl]-4-pyridinyl]amino]phenoxy]-2-pyridinecarboxamide
- 2004664-92-8/4(1H)-Quinolinone, 3-acetyl-8-chloro-2-phenyl-
- 2004677-13-6/1-Hexanol, 2-[(2-amino-7-fluoropyrido[3,2-d]pyrimidin-4-yl)amino]-2-methyl-, (2R)-
- 2004679-56-3/(R)-2-(((R)-2-Hydroxy-1-phenylethyl)amino)-2-methylhexan-1-ol, TsOH
- 2004683-24-1/(2,6-dimethyl)-L-tyrosine benzyl ester hydrochloride
- 2004705-97-7/2H-Indazole, 5-bromo-7-fluoro-2-methyl-
- 2004714-34-3/Propanoic acid, 2,2-dimethyl-, 1,1'-[[(1-hydroxy-2-oxo-3-piperidinyl)phosphinylidene]bis(oxymethylene)] ester
- 2004718-99-2/5-(2,5-Difluorophenyl)-1,3-oxazole
- 2004724-16-5/Mal-L-Dap(Boc)-OH*DCHA
- 2004756-76-5/6-(methylthio)-2-oxo-2H-chromene-3-carboxylic acid
- 200484-69-1/1-Hexanamine, 6-(4-bromophenoxy)-